Sheila Gujrathi

Sheila Gujrathi, M.D., joined OrbiMed as a Venture Advisor. Dr. Gujrathi was the Chief Executive Officer and Co-Founder of Gossamer Bio. Prior to Gossamer, Dr. Gujrathi served as the Chief Medical Officer of Receptos, which Celgene acquired. Previously, Dr. Gujrathi held development leadership positions at Bristol-Myers Squibb and Genentech and was a McKinsey consultant. Dr. Gujrathi received her M.D. and B.S. in biomedical engineering from Northwestern University’s Honors Program in Medical Education and clinically trained at Brigham and Women’s Hospital, UCSF, and Stanford.